Prosecution Insights
Prosecution Insights
21 pending office actions • 13 art units • 17 examiners • 0 of 21 (0%) have an AI response strategy ready • 34 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 20 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 20 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 9 (43%) |
| §102 only | 1 (5%) |
| §112 only | 1 (5%) |
| Double-patenting + other | 1 (5%) |
| No statute on record | 9 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALAM, DANYAL HASSAN | 2 | 100.0% | +0.0% |
| CHESTNUT, BARRY A | 2 | 73.5% | +5.9% |
| HILL, MYRON G | 2 | 66.5% | +19.8% |
| LARA, CAROLINE MONSERRAT | 2 | — | — |
| TRUONG, QUANGLONG N | 1 | 78.6% | +23.4% |
| WERTZ, ASHLEE ELIZABETH | 1 | 45.7% | +33.1% |
| LEWIS, PATRICK T | 1 | 74.3% | +14.5% |
| CREWS, JARET JAMES | 1 | 44.3% | +71.9% |
| PAK, YONG D | 1 | 74.4% | +13.7% |
| ZARA, JANE J | 1 | 70.8% | +15.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18314980 | RESPIRATORY SYNCYTIAL VIRUS VACCINE | HILL, MYRON G | 72d overdue |
| 18682685 | LIPID NANOPARTICLE FORMULATIONS AND METHODS OF SYNTHESIS THEREOF | TRUONG, QUANGLONG N | 46d overdue |
| 18284395 | SYNTHESIS OF TRINUCLEOTIDE AND TETRANUCLEOTIDE CAPS FOR MRNA PRODUCTION | LEWIS, PATRICK T | 43d overdue |
| 18284177 | PURIFICATION AND RECYCLING OF mRNA NUCLEOTIDE CAPS | CREWS, JARET JAMES | 30d overdue |
| 18036992 | RIBONUCLEIC ACID PURIFICATION | ZARA, JANE J | 9d overdue |
| 18291707 | PROCESSES FOR PREPARING LIPID NANOPARTICLE COMPOSITIONS | WERTZ, ASHLEE ELIZABETH | 34d |
| 17928680 | PHENYLALANINE HYDROXYLASE VARIANTS AND USES THEREOF | PAK, YONG D | 75d |
| 17796401 | RESPIRATORY VIRUS IMMUNIZING COMPOSITIONS | HILL, MYRON G | — |
| Art Unit | Apps |
|---|---|
| 1672 | 4 |
| 1615 | 2 |
| 1691 | 2 |
| 1637 | 2 |
| 1671 | 2 |
| 1633 | 2 |
| 1612 | 1 |
| 1652 | 1 |
| 1619 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18682685 | LIPID NANOPARTICLE FORMULATIONS AND METHODS OF SYNTHESIS THEREOF | TRUONG, QUANGLONG N | 1615 | §103 | Non-Final OA | 46d overdue | Pending | Feb 09, 2024 |
| 18291707 | PROCESSES FOR PREPARING LIPID NANOPARTICLE COMPOSITIONS | WERTZ, ASHLEE ELIZABETH | 1612 | Other | Non-Final OA | 34d | Pending | Jan 24, 2024 |
| 18555087 | RESPIRATORY VIRUS COMBINATION VACCINES | ALAM, DANYAL HASSAN | 1672 | Other | Non-Final OA | 9d overdue | Pending | Oct 12, 2023 |
| 18555130 | INFLUENZA-CORONAVIRUS COMBINATION VACCINES | ALAM, DANYAL HASSAN | 1672 | Other | Non-Final OA | 5d overdue | Pending | Oct 12, 2023 |
| 18286705 | EPSTEIN-BARR VIRUS MRNA VACCINES | CHESTNUT, BARRY A | 1672 | Other | Non-Final OA | 2d overdue | Pending | Oct 12, 2023 |
| 18284395 | SYNTHESIS OF TRINUCLEOTIDE AND TETRANUCLEOTIDE CAPS FOR MRNA PRODUCTION | LEWIS, PATRICK T | 1691 | §102 | Non-Final OA | 43d overdue | Pending | Sep 27, 2023 |
| 18284177 | PURIFICATION AND RECYCLING OF mRNA NUCLEOTIDE CAPS | CREWS, JARET JAMES | 1691 | §103 | Non-Final OA | 30d overdue | Pending | Sep 26, 2023 |
| 18282097 | THERAPEUTIC USE OF SARS-COV-2 MRNA DOMAIN VACCINES | CHESTNUT, BARRY A | 1672 | §103 | Non-Final OA | 17d overdue | Pending | Sep 14, 2023 |
| 17928680 | PHENYLALANINE HYDROXYLASE VARIANTS AND USES THEREOF | PAK, YONG D | 1652 | DPOther | Final Rejection | 75d | Pending | Jul 18, 2023 |
| 18036992 | RIBONUCLEIC ACID PURIFICATION | ZARA, JANE J | 1637 | §103 | Non-Final OA | 9d overdue | Pending | May 15, 2023 |
| 18314980 | RESPIRATORY SYNCYTIAL VIRUS VACCINE | HILL, MYRON G | 1671 | §103 | Final Rejection | 72d overdue | Pending | May 10, 2023 |
| 18161857 | METHODS FOR PREPARING PARTICLES AND RELATED COMPOSITIONS | GREENE, IVAN A | 1619 | §103 | Final Rejection | 45d overdue | Pending | Jan 30, 2023 |
| 18012094 | LNP COMPOSITIONS COMPRISING MRNA THERAPEUTICS WITH EXTENDED HALF-LIFE | RYAN, DOUGLAS CHARLES | 1635 | Other | Non-Final OA | 16d overdue | Pending | Dec 21, 2022 |
| 18008139 | BACTERIAL STRAINS FOR DNA PRODUCTION | TINSLEY, BRENDAN THOMAS | 1634 | §103 | Non-Final OA | 1d overdue | Pending | Dec 02, 2022 |
| 17925114 | RNA FORMULATIONS FOR HIGH VOLUME DISTRIBUTION | LARA, CAROLINE MONSERRAT | 1633 | Other | Non-Final OA | 16d overdue | Pending | Nov 14, 2022 |
| 17925125 | RNA FORMULATIONS FOR HIGH VOLUME DISTRIBUTION, AND METHODS OF USING THE SAME FOR TREATING COVID-19 | LARA, CAROLINE MONSERRAT | 1633 | Other | Non-Final OA | 22d overdue | Pending | Nov 14, 2022 |
| 17796401 | RESPIRATORY VIRUS IMMUNIZING COMPOSITIONS | HILL, MYRON G | 1671 | Other | Non-Final OA | — | Pending | Jul 29, 2022 |
| 17792554 | METHODS OF PREPARING LIPID NANOPARTICLES | NGUYEN, NGOC-ANH THI | 1615 | §103 | Non-Final OA | 30d | Pending | Jul 13, 2022 |
| 17276983 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | JOHNSON, ALLISON MARIE | 1638 | §103 | Non-Final OA | 32d overdue | Pending | Mar 17, 2021 |
| 17255949 | PERSONALIZED CANCER VACCINE EPITOPE SELECTION | CANELLA, KAREN A | 1643 | Other | Final Rejection | 112d overdue | Pending | Dec 23, 2020 |
| 16482844 | RNA CANCER VACCINES | ANGELL, JON E | 1637 | §112 | Final Rejection | 31d overdue | Pending | Aug 01, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial